Einvestment Fund: “COVID-19 Vaccine-Driven Stocks Surge as Vaccine Developers Approach The Final Stage of Testing”

Must Read

List of United Bank for Africa (UBA) Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...

List of Access Bank Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number which usually identifies both the bank and the branch where an account is...

How To Block Your Bank Account And SIM Card In Case Of Emergency

Losing your phone and wallet or having them stolen can be very frustrating. However, in case that happens to...
- Advertisement -

LISBON, PORTUGAL – Media OutReach – 13 October 2020 –  Einvestment Fund has reported the
continued growth of COVID-19 vaccine-driven stocks. This occurred after the leading global biotech firms have
finally come to the start of crucial late-stage trials of their experimental
coronavirus vaccine. 

Einvestment Fund: "COVID-19 Vaccine-Driven Stocks Surge as Vaccine Developers Approach The Final Stage of Testing"

- Advertisement -

The pharmaceutical
sector offers tremendous investment opportunities. Today it is the
second-largest segment of the US stock market by capitalization – about $ 4
trillion, analysts at Einvestment say. Recently, the health problem’s urgency
has significantly increased — the pandemics such as COVID-19, the growth of
oncological and hereditary diseases, diabetes, obesity, etc. are creating ever
more significant threats to humanity.

This growth is reflected
in an increase in stocks’ value, offering investors exceptional opportunities
for long-term capital appreciation. Once the long-awaited coronavirus vaccine
is in place, and the world begins to return to normal, monetary authorities may
change attitudes towards economic incentives. As for today’s situation at
Einvestment, the average gain of three vaccine-sensitive
positions in the investment portfolio exceeded
92% since June 2020
when the fund managers entered the vaccine rally.

- Advertisement -

Pfizer and Moderna
officials stated they should know before December whether their vaccines are
safe and effective. Still, the WHO and global government officials do not
expect any serum to be commercially accessible until next year.

Read Also:  Citibank Extends 2019 Citi Tax Season Loan

The Health
Care sector’s share of positions in the fund
portfolio now exceeds 8%. In the words of
Managing Director, Peter Derksen: “We
hold significant share of Health Care positions in the investment portfolio,
and in early June of this year we allocated 2.8% of AUM to Biotech companies engaged
in vaccine development”
Biotech, as
well as the AI & Robotics sector, lead the “Top Gainers of 2020” list in the fund’s portfolio as of
Q4 2020. 

Read Also:  Eagle Hospitality Trust Sponsor Urges Collaboration to Save REIT

- Advertisement -

Einvestment’s technology-driven approach is
tailored to continue improving fund’s
performance and accelerating the market value growth of assets under management. Before allocating the funds to any assets, Einvestment experts initiate
an in-depth research process to develop a transparent framework of risks, opportunities,
goals, and deadlines. The fund’s segregated investment portfolios are
loaded with the appropriate mix of assets to ensure exposure to trending
sectors and most promising assets.

Einvestment Fund: "COVID-19 Vaccine-Driven Stocks Surge as Vaccine Developers Approach The Final Stage of Testing"

- Advertisement -
Einvestment Fund: "COVID-19 Vaccine-Driven Stocks Surge as Vaccine Developers Approach The Final Stage of Testing" - Brand SpurEinvestment Fund: "COVID-19 Vaccine-Driven Stocks Surge as Vaccine Developers Approach The Final Stage of Testing" - Brand Spur

Subscribe to BrandSpur Ng

Subscribe for latest updates. Signup to best of brands and business news, informed analysis and opinions among others that can propel you, your business or brand to greater heights.

- Advertisement -
Einvestment Fund: "COVID-19 Vaccine-Driven Stocks Surge as Vaccine Developers Approach The Final Stage of Testing" - Brand SpurEinvestment Fund: "COVID-19 Vaccine-Driven Stocks Surge as Vaccine Developers Approach The Final Stage of Testing" - Brand Spur

Latest News

The new 2022 Volkswagen Golf R brings more power, tech and fun than ever before

It has been just under two decades since Volkswagen revealed the first Golf R32, a then-unexpected combination of the...

WorldRemit Launches a New Price Drop on Transfers to Nigeria this Black Friday

WorldRemit, a leading global digital payments company, has announced the launch of its new zero percent pricing for international transfers to Nigeria. The new lowered...

MTN enhances Business Growth at ICT and Business Skills Programme

MTN Nigeria, as part of its ICT and Business Skills programme, hosted young Nigerians to a capacity-building workshop. The workshop was facilitated by trainers...

Orange launches its 5G network by making quality of service its priority

Orange announces the launch of its 5G network in 15 French municipalities, as of 3 December 2020, including Nice, Marseille, Le Mans, Angers and...

BREAKING: Konga Bulk offers 35,000 laptops, PCs, others at huge discounts Friday

Konga, Nigeria’s foremost e-Commerce giant, is set to make available over 35,000 units of laptops, Personal Computers (PCs), tablets and complimentary printers at giveaway...
- Advertisement -
BrandsPur Weekly Cartoons
- Advertisement -Einvestment Fund: "COVID-19 Vaccine-Driven Stocks Surge as Vaccine Developers Approach The Final Stage of Testing" - Brand SpurEinvestment Fund: "COVID-19 Vaccine-Driven Stocks Surge as Vaccine Developers Approach The Final Stage of Testing" - Brand Spur